A4i

A4i is a software company developing a digital therapeutic for schizophrenia and psychosis. The software consists of a clinically-prescribed mobile app and clinical portal that allow clinicians to monitor patients’ condition, and enables patients to manage their own condition. The patient app features a patent-protecte

A4i is active in the health space.

Profile

A4i is a software company developing a digital therapeutic for schizophrenia and psychosis. The software consists of a clinically-prescribed mobile app and clinical portal that allow clinicians to monitor patients’ condition, and enables patients to manage their own condition. The patient app features a patent-protected, clinically-tested engagement feed, and audio hallucination recognition tool that gives […]

A4i is positioned in health, a segment that rewards a clear, focused offering.

The company is listed at the Creative Destruction Lab alumni company stage of development.

Website: a4i.me